NLE Renal & Urinary Nursing — UTI & Inflammatory Renal DisordersSummary

A UTI is the presence of pathogenic microorganisms (most commonly Escherichia coli) in the normally sterile urinary tract. The ascending route—bacteria ascending from the perineum/rectum through the urethra into the bladder and potentially the ureters and kidneys—is the classic pathway. In females, the short urethra (approximately 4 cm) and anatomic proximity to the anus increase risk; in males, the longer urethra (approximately 20 cm) is protective. Key risk factors include sexual activity, pregnancy, urinary retention, obstruction, indwelling catheters, diabetes, and urinary stasis. UTIs are classified as lower (cystitis—bladder; urethritis—urethra) or upper (pyelonephritis—renal pelvis and parenchyma). Lower UTI produces dysuria, frequency, urgency, suprapubic pain, and cloudy/foul-smelling urine without systemic fever. Upper UTI causes systemic manifestations: high fever, chills, flank pain, and costovertebral angle (CVA) tenderness.

Cystitis presents with dysuria (painful, burning urination), urinary urgency and frequency, suprapubic pain or pressure sensation, and urine that appears cloudy, turbid, or foul-smelling. Some patients report hematuria (blood in urine). Crucially, fever is NOT typical of uncomplicated cystitis; if fever is present, suspect upper UTI (pyelonephritis) or systemic infection. In older adults, the classic lower-UTI symptoms may be entirely absent—new-onset confusion, incontinence, falls, or behavioral changes may be the only clues. Diagnosis relies on urinalysis showing positive leukocyte esterase, nitrites (suggesting Gram-negative bacteria), pyuria (WBCs), and bacteria. Urine culture and sensitivity (obtained before antibiotics) confirm the organism and direct antimicrobial choice. The classic significant bacteriuria threshold is >100,000 (10⁵) colony-forming units per milliliter (CFU/mL), though lower counts may be significant in symptomatic patients.

Pyelonephritis is bacterial infection and inflammation of the renal pelvis and kidney parenchyma, typically resulting from ascending lower UTI, obstruction, or vesicoureteral reflux. Manifestations include all lower-UTI symptoms plus systemic signs: high fever (often >39°C/102°F), rigors/chills, flank or lower back pain, and positive CVA tenderness (pain elicited by percussion of the costovertebral angle at the posterior flank). Nausea, vomiting, and malaise are common. Laboratory findings include elevated WBC count, left shift in differential, elevated creatinine/BUN, and urine with WBC casts. Uncomplicated pyelonephritis may be treated with oral fluoroquinolones or cephalosporins on an outpatient basis; complicated cases or sepsis require IV antibiotics and hospitalization. Chronic or recurrent pyelonephritis can scar the renal parenchyma, leading to chronic kidney disease (CKD) and progressive loss of renal function.

APSGN is an immune-complex-mediated glomerular inflammation triggered by group A beta-hemolytic streptococcal infection of the throat (pharyngitis) or skin (impetigo). Approximately 1–2 weeks after the acute streptococcal infection (often after the acute infection has seemingly resolved), immune complexes (antibody-antigen pairs) deposit in the glomerular basement membrane, activating complement and triggering an inflammatory cascade. This damages the glomerular filtering apparatus, reducing glomerular filtration rate (GFR) and increasing permeability. Fluid and nitrogenous wastes are retained, leading to oliguria, edema, and hypertension. The hallmark manifestation is gross hematuria producing urine that is tea-colored, cola-colored, or smoky in appearance—a classic NLE presentation. Additional findings include periorbital and facial edema (typically mild, worse upon waking), hypertension (from fluid retention and renin-angiotensin-aldosterone system activation), mild-to-moderate proteinuria, and elevated BUN/creatinine. The diagnosis is supported by elevated antistreptolysin-O (ASO) titer (evidence of recent streptococcal infection) and depressed serum complement (C3), indicating consumption by immune-complex formation.

Management of APSGN and other glomerulonephritides centers on protecting renal function and preventing complications. Blood pressure monitoring is critical—severe hypertension risks hypertensive encephalopathy (headache, confusion, seizures, cerebral edema), a medical emergency treated with antihypertensive agents and diuretics. Fluid restriction is imposed during the oliguric/edematous phase to prevent fluid overload, pulmonary edema, and heart failure; intake is typically limited to insensible losses plus measured urine output. Sodium restriction (<2 g/day or approximately 3 g/day of salt) reduces fluid retention and eases hypertension management. Protein intake is restricted if BUN is markedly elevated (>50 mg/dL) to reduce uremic symptoms and the burden on the kidneys; restriction is usually temporary as GFR recovers. Daily weight measurement (same time, same clothing, same scale) and strict intake-and-output documentation detect fluid imbalance early. Treat any remaining streptococcal infection with penicillin to eliminate the antigen source. Most children recover renal function completely within weeks; adults have a 5–10% risk of progression to chronic GN.

Nephrotic syndrome is a clinical entity defined by massive proteinuria (typically >3.5 g/day in adults, or >40 mg/kg/day in children), not by a single disease. It results from severe glomerular permeability defects allowing albumin and other plasma proteins to escape into the urine. The underlying causes include minimal-change disease (most common in children, highly steroid-responsive), focal segmental glomerulosclerosis (FSGS), membranoproliferative GN, and secondary causes (diabetes, systemic lupus erythematosus [SLE], amyloidosis, infections). The pathophysiology creates a characteristic cascade: massive urinary albumin loss → hypoalbuminemia (low serum albumin) → reduced plasma oncotic pressure → fluid shifts from intravascular to interstitial space → generalized edema and weight gain. Urine becomes foamy or frothy from the protein content. The liver responds to protein loss by synthesizing more lipoproteins, causing hyperlipidemia (elevated cholesterol and triglycerides). Importantly, blood pressure is typically normal or low in pure nephrotic syndrome (unlike the hypertension of glomerulonephritis), reflecting fluid depletion of the intravascular space despite clinical edema. Patients lose immunoglobulins in the urine, making infection a major cause of morbidity and mortality.

First-line therapy for nephrotic syndrome is corticosteroids (prednisone), especially in children with minimal-change disease, which has a >90% response rate to steroids. The anti-inflammatory and immunosuppressive effects of corticosteroids reduce glomerular inflammation and permeability, inducing remission of proteinuria. In steroid-resistant cases or disease recurrence, immunosuppressive agents such as cyclophosphamide, mycophenolate, or calcineurin inhibitors (tacrolimus, cyclosporine) are added. Loop diuretics (furosemide) are used judiciously to manage edema; they are combined with albumin infusion in severely hypoproteinemic patients because diuretics alone may worsen renal perfusion. ACE inhibitors or angiotensin II receptor blockers (ARBs) are cornerstone agents that reduce intraglomerular pressure, decrease proteinuria, and slow progression to CKD—their renoprotective effect extends beyond blood-pressure lowering. HMG-CoA reductase inhibitors (statins) are used for dyslipidemia. Anticoagulation may be considered in patients with nephrotic-range proteinuria because loss of anticoagulant proteins (antithrombin III, protein C) increases thrombotic risk. Dietary management includes moderate protein intake (not the high-protein diet of the past—current guidelines recommend normal or slightly elevated protein only to replace losses) and strict sodium restriction (<2 g/day) to facilitate fluid management.

Nursing management of nephrotic syndrome integrates multiple care foci. Daily weight measurement (same time, clothing, scale) and abdominal girth measurement detect subtle changes in fluid status; a gain of 0.5 kg or more in one day suggests fluid accumulation. Strict intake-and-output recording guides diuretic and fluid management. Edematous skin is vulnerable to breakdown; meticulous skin care (cleansing, drying thoroughly, frequent position changes, avoiding pressure) prevents ulceration and infection. Monitor for signs of fluid overload (crackles in lung bases, orthopnea, increased respiratory rate) and hypovolemic hypotension (dizziness, syncope, oliguria). Infection prevention is paramount: teach patients to avoid crowds during upper-respiratory-illness season, to report fever or symptoms immediately, and to maintain scrupulous hygiene. Nutritional support addresses the ongoing protein loss—collaborate with dietitians to ensure adequate (not excess) protein intake and calorie sufficiency while restricting sodium. Monitor serum albumin and prealbumin levels; persistent hypoalbuminemia despite steroid therapy indicates either poor response or inadequate nutrition. Educate patients about medication adherence (especially never stopping steroids abruptly, which risks adrenal crisis) and the expected timeline to remission (weeks to months in steroid-responsive cases).

Urolithiasis (renal calculi, kidney stones) forms when urinary solutes precipitate and crystallize. Calcium oxalate and calcium phosphate stones account for approximately 75–80% of cases; other compositions include struvite (magnesium-ammonium-phosphate, associated with UTI caused by urease-producing bacteria, forming large 'staghorn' stones that may require surgical removal), uric acid (associated with gout, acidic urine), and cystine (rare, genetic). Risk factors include dehydration and low urine output (the single most modifiable risk factor), immobility, urinary stasis, hyperparathyroidism/hypercalcemia, gout, recurrent UTI, dietary excess of stone-forming substances (oxalate in spinach/nuts, purines in red meat/organ meats), and family history. The acute presentation is renal colic—sudden, severe, excruciating flank pain (8–9/10 on pain scales) that radiates to the groin and genitalia as the stone descends the ureter. The pain is unrelenting and colicky (spasm-like). Patients are restless, unable to find a comfortable position (unlike peritonitis patients who lie still). Associated symptoms include hematuria (from ureteral trauma), nausea/vomiting, diaphoresis, and urinary frequency/urgency. Diagnostics: non-contrast helical CT (CT KUB) is the gold standard for stone detection and location; KUB radiographs may show radiopaque stones; ultrasound is useful in pregnancy; urinalysis shows hematuria and may show crystals. All urine must be strained to catch the stone for composition analysis, which guides prevention.

Using Maslow's hierarchy of needs, pain relief is the physiologic safety priority in renal colic—the pain is so severe that patients may become suicidal if untreated. Administer opioids (morphine, hydromorphone) and NSAIDs (ketorolac/Toradol) as ordered; NSAIDs are particularly effective because they reduce prostaglandin-mediated inflammation and ureteral spasm. Antiemetics (ondansetron, metoclopramide) address vomiting, which prevents adequate oral intake. Increase fluid intake (2.5–3 L/day unless contraindicated) to dilute urine and increase urinary flow, promoting stone passage. Encourage ambulation and movement—paradoxically, activity promotes stone movement through the ureter. STRAIN ALL URINE through gauze or a urine strainer; ensure every void is strained and inspected. Any stone passed must be collected, labeled, and sent for composition analysis (critical for prevention). Monitor for signs of obstruction: fever (indicating possible concurrent infection), worsening pain despite analgesia, decreased or absent urine output from one kidney (suggesting ureteral obstruction), elevated creatinine, or nausea/vomiting that prevents fluid intake. Obstruction with infection (urosepsis) is a urologic emergency requiring urgent decompression (percutaneous nephrostomy or ureteral stent). Once the acute episode resolves, arrange imaging to confirm stone passage and rule out retained fragments.

Prevention strategies are tailored to stone composition, discovered by analyzing any passed stone. For calcium oxalate stones (most common): increase fluid intake (the universal preventive measure—aim 2.5–3 L/day urine output), avoid excess dietary oxalate (spinach, rhubarb, beets, chocolate, tea, nuts), maintain adequate dietary calcium (paradoxically, restricting calcium can increase oxalate absorption and stone risk—current guidelines recommend normal calcium intake), and acidify urine if appropriate. For uric acid stones: follow a low-purine diet (limit organ meats, red meat, shellfish, high-fructose corn syrup), alkalinize urine (pH >6.5 increases uric acid solubility) using potassium citrate or sodium citrate, treat gout with allopurinol, and ensure adequate hydration. For struvite stones: treat and prevent UTI aggressively with antibiotics and urine cultures; these infections (often Proteus, Klebsiella) produce urease, which alkalinizes urine and promotes struvite precipitation. For cystine stones (rare, autosomal recessive): extremely high fluid intake, alkaline urine, and sometimes penicillamine (a chelating agent that reduces cystine concentration). The absolute foundation for all stone types is HIGH FLUID INTAKE—the single most important preventive intervention. Encourage patient compliance with 24-hour urine collection (to assess urinary chemistries and guide pharmacologic prevention) and follow-up imaging.

Each disorder carries specific serious complications. UTI/pyelonephritis: ascending spread to urosepsis (fever, hypotension, tachycardia, altered mental status—a sepsis syndrome requiring ICU-level care, broad-spectrum antibiotics, and aggressive fluid resuscitation); renal scarring from recurrent or untreated pyelonephritis leading to CKD; in pregnancy, preterm labor and fetal loss; chronic renal dysfunction if scarring is extensive. Glomerulonephritis: hypertensive encephalopathy (neurologic emergency with headache, seizures, altered consciousness from severe HTN-induced cerebral edema, treated with antihypertensives and diuretics); fluid overload precipitating acute decompensated heart failure (pulmonary edema, orthopnea, crackles); acute kidney injury if GFR drops sharply; progression to chronic GN and eventual CKD. Nephrotic syndrome: thromboembolism (loss of anticoagulant proteins—antithrombin III, protein C, and protein S—with retained prothrombotic factors elevates risk of deep-vein thrombosis and pulmonary embolism, especially with immobility); severe, life-threatening infections (loss of immunoglobulins + immunosuppression from corticosteroids create a perfect storm for infection—bacterial peritonitis, pneumonia, tuberculosis reactivation); malnutrition and growth retardation in children from ongoing protein loss and anorexia; acute kidney injury from NSAIDs or ACE inhibitors in volume-depleted states. Urolithiasis: complete obstruction of a ureter leading to hydronephrosis (dilation of the renal collecting system from backed-up urine) and permanent renal parenchymal damage if not relieved promptly (typically within 2–4 weeks); obstruction combined with infection is a urologic emergency requiring immediate decompression.

Pregnant women: asymptomatic bacteriuria occurs in 2–10% of pregnancies; unlike in non-pregnant patients (where asymptomatic bacteriuria does not require treatment), pregnant patients MUST be screened and treated because bacteriuria progresses to pyelonephritis in 20–40% of untreated cases, and pyelonephritis in pregnancy precipitates preterm labor, low birth weight, and fetal loss. Screen with a urine culture at the first prenatal visit and treat with pregnancy-safe antibiotics (ampicillin, cephalexin, nitrofurantoin—avoid trimethoprim-sulfamethoxazole in the third trimester and fluoroquinolones). Pyelonephritis in pregnancy is a medical emergency requiring hospitalization and IV antibiotics. Older adults: UTI presentation is atypical—classic dysuria/frequency may be entirely absent. Instead, watch for new-onset confusion, delirium, incontinence (or worsening of chronic incontinence), functional decline, falls, or behavioral changes (restlessness, withdrawal). Fever may be absent in older adults even with serious infection. This atypical presentation leads to underdiagnosis and delayed treatment; a high index of suspicion is essential. Do not anchor on the absence of dysuria. Children: post-streptococcal glomerulonephritis and minimal-change nephrotic syndrome are largely pediatric diseases. In children with recurrent UTIs, evaluate for structural abnormalities (vesicoureteral reflux [VUR], posterior urethral valves) that predispose to ascending infection and renal scarring. Prophylactic antibiotics may be used in some children with VUR. Growth monitoring in children with chronic renal disease is crucial because stunted growth and developmental delay are consequences of untreated or poorly controlled renal disease.

Under RA 9173 (The Philippine Nursing Act of 2002), nurses are authorized to perform independent nursing functions including assessment, health education, and monitoring of patients with renal and urinary disorders across primary, secondary, and tertiary healthcare levels. In primary care settings (barangay health centers, rural health units), nurses screen for UTI symptoms, educate on prevention (hygiene, hydration), and provide referral for diagnosis and treatment. In secondary hospitals (provincial/city level), nurses implement physician orders for antibiotic therapy, fluid management, and dietary restrictions; they monitor for complications and provide patient/family education. In tertiary hospitals (medical centers, university hospitals), nurses collaborate in the care of complex cases (nephrotic syndrome with infection, obstruction with sepsis, acute kidney injury) and may lead multidisciplinary teams. The NCM (Nursing Care Management) framework guides the nursing process: Assessment (history, physical exam, diagnostic data), Diagnosis (NANDA nursing diagnoses such as 'Excess Fluid Volume,' 'Risk for Infection,' 'Acute Pain,' 'Deficient Knowledge'), Planning (client-centered goals), Implementation (interventions based on level of care), and Evaluation (goal attainment). In Philippine settings, nurses often work with limited resources—promoting high-fluid intake and prevention is cost-effective and feasible. The Department of Health (DOH) guidelines on UTI management and the RA 9173-defined scope support nurses conducting urinalysis, obtaining urine cultures, providing health education, and monitoring treatment response—all essential in the Philippines' nurse-driven care model.

Maslow's hierarchy of needs (physiologic, safety, love/belonging, esteem, self-actualization) guides nursing prioritization. In acute renal colic, the physiologic need for pain relief and fluid balance is paramount—renal colic pain is so severe that meeting this need takes precedence; oxygen, nutrition, and elimination follow. In pyelonephritis with sepsis, airway/breathing (physiologic), hemodynamic stability (safety through IV fluids and vasopressors if needed), and infection control (safety) are top priorities. In glomerulonephritis, preventing complications (hypertensive encephalopathy, fluid overload—safety needs) guides frequent BP monitoring and fluid restriction. In nephrotic syndrome, the physiologic needs (nutrition, fluid balance, infection prevention) and safety (infection prevention is a major focus because infection is a leading cause of death) drive the care plan; once acute complications are prevented, teaching about medication adherence and lifestyle supports self-actualization. This framework ensures that nursing priorities align with immediate life threats while maintaining attention to longer-term management and patient education.

Lower UTI (cystitis with dysuria/frequency) can ascend to become upper UTI (pyelonephritis with fever/flank pain/CVA tenderness). Untreated or recurrent pyelonephritis leads to renal scarring → chronic kidney disease. Obstruction accelerates this progression. Prevention (front-to-back wiping, post-coital voiding, hydration) and prompt treatment interrupt the ascending chain.

Group A strep infection (throat/skin) → antibody formation → immune-complex (Ab-Ag) formation → deposition in glomerular basement membrane → complement activation → inflammation → glomerular damage → reduced GFR → fluid/waste retention → oliguria, edema, hypertension. The 1–2 week lag between strep and GN manifestations reflects the time needed for immune-complex accumulation and complement consumption.

Glomerular permeability defect → massive proteinuria → urinary albumin loss → hypoalbuminemia → reduced plasma oncotic pressure → fluid shift to interstitium → edema and weight gain. The liver responds to protein loss by ↑lipoproteins → hyperlipidemia. Loss of immunoglobulins → infection risk. Loss of anticoagulant proteins → thrombosis risk. These cascades explain all the classic findings and nursing interventions.

Dehydration/low urine output (most modifiable) → crystal precipitation; treated by ↑fluids. Dietary oxalate excess → calcium oxalate stones; treated by dietary modification. Gout/hyperuricemia → uric acid stones; treated by low-purine diet + urine alkalinization + allopurinol. Recurrent UTI → struvite stones; treated by aggressive UTI prevention/treatment. Hyperparathyroidism → hypercalcemia → calcium stones; treated by correcting the underlying disorder. Understanding these relationships individualizes prevention.

Renal colic from stone passage is intensely painful but usually self-limited. If the stone lodges and causes complete obstruction, urine backs up → hydronephrosis. If infection supervenes on obstruction (urosepsis), it becomes a urologic emergency requiring immediate decompression. The presence of fever + worsening pain + oliguria signals this escalation and demands urgent intervention.

GN: hematuria + hypertension + mild proteinuria = glomerular bleeding + fluid retention (high BP). Nephrotic: massive proteinuria + normal/low BP + severe edema = protein loss → intravascular depletion despite clinical edema. These opposite presentations require opposite management: GN requires fluid/sodium restriction and BP control; nephrotic requires diuretics + albumin + ACE inhibitors. Confusing them leads to harmful care.

In UTI/pyelonephritis, infection is the PRIMARY PATHOLOGY—treat with antibiotics, prevent recurrence. In nephrotic syndrome, infection is a COMPLICATION—prevent through hygiene, immunization, and early recognition. In nephrotic syndrome with concurrent UTI (or any infection), both processes must be managed: antibiotics for infection + steroids/ACE inhibitors for nephrotic + aggressive infection prevention.

In glomerulonephritis (oliguria, hypertension, edema, fluid overload risk): RESTRICT fluids and sodium. In nephrotic syndrome (despite edema, intravascular depletion, albumin loss): INCREASE fluids or use albumin + diuretics judiciously. In renal colic: INCREASE fluids to promote stone passage. Misunderstanding these fluid dynamics leads to harm—e.g., restricting fluids in nephrotic syndrome worsens azotemia; not restricting fluids in GN causes pulmonary edema.

In GN with markedly elevated BUN: restrict protein to reduce uremic symptoms. In nephrotic syndrome: normal-to-modest protein (NOT high—current evidence), matched to replace urinary losses without excess. In CKD: restrict protein to slow progression. In acute kidney injury: restrict protein. The principle: excess protein worsens uremia in low-GFR states; inadequate protein worsens malnutrition. Tailoring requires understanding GFR and nitrogen balance.

Acute renal colic: pain relief (physiologic) is TOP priority. Pyelonephritis with sepsis: airway, breathing, hemodynamic stability (physiologic/safety). GN with HTN: safety (preventing hypertensive encephalopathy, fluid overload). Nephrotic syndrome: safety (infection prevention is paramount), then nutrition (protein loss). Longer-term across all: education and self-care (self-actualization). Exam questions test whether you prioritize correctly using this framework.

Elevated ASO titer (antistreptolysin-O) indicates recent streptococcal infection—the trigger for APSGN. Depressed serum C3 indicates complement consumption in immune-complex formation—the mechanism of glomerular damage. Together, these findings + cola-colored urine + hypertension + RBC casts = APSGN diagnosis. Understanding this pattern helps distinguish APSGN from other GN types (IgA nephropathy, lupus nephritis) that have different diagnostic markers.